ARCHIVES

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Eleven Chemicals Rated for Tests

September 1, 1978

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

In Brief: NCI Would Get Extra $115 Million Over Three Years Under Budget Amendment By Alabama Senator

June 4, 1982

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

NCI-Approved Clinical Trials

September 28, 2001